ABCB1 C3435T Genetic Polymorphism on Population Pharmacokinetics of Methotrexate After Hematopoietic Stem Cell Transplantation in Korean Patients: A Prospective Analysis

Abstract Background Methotrexate (MTX) is often used to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). However, MTX has great pharmacokinetic variability and its use can result in fatal complications and/or infections after HSCT. Objectives...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical therapeutics 2012-08, Vol.34 (8), p.1816-1826
Hauptverfasser: Kim, In-Wha, PhD, Yun, Hwi-yeol, PhD, Choi, Boyoon, MS, Han, Nayoung, MS, Park, Seon-Yang, MD, PhD, Lee, Eun Sook, PharmD, Oh, Jung Mi, PharmD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!